Literature DB >> 18234391

SCALP syndrome: sebaceous nevus syndrome, CNS malformations, aplasia cutis congenita, limbal dermoid, and pigmented nevus (giant congenital melanocytic nevus) with neurocutaneous melanosis: a distinct syndromic entity.

Joseph Lam1, Magdalene A Dohil, Lawrence F Eichenfield, Bari B Cunningham.   

Abstract

Nevus sebaceus syndrome (SNS) is a constellation of nevus sebaceus with extracutaneous findings, including the ophthalmologic nervous, and musculoskeletal systems. Didymosis aplasticosebacea is a recently described entity consisting of aplasia cutis congenita and nevus sebaceus, implying twin spotting (didymosis). We describe a neonate with a nevus sebaceus on the scalp and a limbal dermoid on her left eye. Contiguous with the nevus sebaceus was a giant congenital melanocytic nevus and numerous areas of membranous aplasia cutis congenita. We propose the acronym SCALP (nevus sebaceus, central nervous system malformations, aplasia cutis congenita, limbal dermoid, pigmented nevus) to summarize the unique features of this case and review the two similar cases in the literature.

Entities:  

Mesh:

Year:  2008        PMID: 18234391     DOI: 10.1016/j.jaad.2007.09.029

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  3 in total

Review 1.  A practical approach to the evaluation and treatment of an infant with aplasia cutis congenita.

Authors:  S R Humphrey; X Hu; K Adamson; A Schaus; J N Jensen; B Drolet
Journal:  J Perinatol       Date:  2017-10-19       Impact factor: 2.521

2.  Aplasia Cutis Congenita in a Newborn: A Rare Case.

Authors:  Aditya Pratap Singh; Arun Kumar Gupta; Rajlaxmi Pardeshi; Arvind Kumar Shukla
Journal:  J Indian Assoc Pediatr Surg       Date:  2018 Jul-Sep

3.  SCALP syndrome: What is it and its ophthalmic manifestations.

Authors:  Geoffrey Z P Chan; Louis Stevenson; Swati Sinkar; Geoffrey C Lam
Journal:  Am J Ophthalmol Case Rep       Date:  2018-04-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.